However, CEO Joe Almeida stressed that the earliest that new products could start to ship from the plant is late November.

The medical supply manufacturer said initial batches will not be ready to ship until late November at the earliest.

Stifel Nicolaus analyst Rick Wise maintained a Buy rating on Baxter International (BAX – Research Report) today and set a price target of ...

Baxter International cut its annual profit forecast on Friday due to a hurricane-related hit to its intravenous solutions facility, sending its shares down 3.3% in premarket trading.

Baxter International (BAX) stock slips as the company with its Q3 2024 results lowers guidance to reflect a $200M revenue hit ...

With a market cap of $18.3 billion, Baxter International Inc. (BAX) operates in the healthcare and medical technology sector.

Medical device maker Baxter International said on Thursday it has restarted the highest-throughput intravenous solutions manufacturing line at its North Carolina facility, which was impacted by ...

Baxter International's Q3 2024 adjusted EPS of $0.80 beat estimates, driven by strong Medical Products & Therapies sales and ...

Diversified and Innovative Product Portfolio: Baxter's strength lies in its diversified range of medical products and ...

Baxter International Inc (BAX) reports a 4% sales increase and surpasses EPS guidance, while navigating operational impacts ...

Baxter International Inc. (NYSE:BAX), a global medtech leader, will present at the Jefferies London Healthcare Conference on Wednesday, November 20, 2024. Joel Grade, Baxter's chief financial officer, ...